RESEARCH AND DEVELOPMENT EXPENSES

12 Months Ended

Dec. 31, 2017

Research And Development Expenses

NOTE 23 - RESEARCH AND DEVELOPMENT EXPENSES

Research and development expenses, excluding stock-based compensation and depreciation expenses, allocated to our major research and development programs are as follows:

In Thousands of US Dollars
	For the Year Ended December 31,
Research and Development Program	2017		2016		2015
Research and Development Program	$	1	$	36	$	34
Alzheimer’s Disease: Therapeutics		2		4		9
Anti-Infectives		4		3		5
BPH (Enlarged Prostate) and Prostate Cancer Therapeutics		5,268		2,675		2,920
Tobacco Exposure Tests: NicAlert™ and TobacAlert™		9		4		-
Total	$	5,284	$	2,722	$	2,968